The role of impulsivity in relapse vulnerability

Current Opinion in Neurobiology

Volumn 23, Issue 4, 2013, Pages 700-705

  Pattij, Tommy ^a   De Vries, Taco J ^a,b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ATOMOXETINE; DEXAMPHETAMINE; METHADONE; METHYLPHENIDATE;

ABSTINENCE; ALCOHOLISM; ATTENTION DEFICIT DISORDER; BEHAVIORAL SCIENCE; CLINICAL OBSERVATION; COCAINE DEPENDENCE; DECISION MAKING; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DRUG DEPENDENCE; DRUG EFFECT; DRUG SEEKING BEHAVIOR; HEROIN DEPENDENCE; HUMAN; IMPULSIVENESS; NONHUMAN; PRIORITY JOURNAL; RELAPSE; REVIEW; SMOKING CESSATION; TREATMENT OUTCOME;

EID: 84881107392     PISSN: 09594388     EISSN: 18736882     Source Type: Journal    
DOI: 10.1016/j.conb.2013.01.023     Document Type: Review

References (64)

1. De Wit H. Impulsivity as a determinant and consequence of drug use: a review of underlying processes. Addict Biol 2009, 14:22-31.
2. Ersche K.D., Sahakian B.J. The neuropsychology of amphetamine and opiate dependence: implications for treatment. Neuropsychol Rev 2007, 17:317-336.
3. Verdejo-Garcia A., Lawrence A.J., Clark L. Impulsivity as a vulnerability marker for substance-use disorders: review of findings from high-risk research, problem gamblers and genetic association studies. Neurosci Biobehav Rev 2008, 32:777-810.
4. Jentsch J.D., Taylor J.R. Impulsivity resulting from frontostriatal dysfunction in drug abuse: implications for the control of behavior by reward-related stimuli. Psychopharmacology (Berl) 1999, 146:373-390.
5. Tarter R.E., Kirisci L., Mezzich A., Cornelius J.R., Pajer K., Vanyukov M., Gardner W., Blackson T., Clark D. Neurobehavioral disinhibition in childhood predicts early age at onset of substance use disorder. Am J Psychiatry 2003, 160:1078-1085. See Ref. [7].
6. Nigg J.T., Wong M.M., Martel M.M., Jester J.M., Puttler L.I., Glass J.M., Adams K.M., Fitzgerald H.E., Zucker R.A. Poor response inhibition as a predictor of problem drinking and illicit drug use in adolescents at risk for alcoholism and other substance use disorders. J Am Acad Child Adolesc Psychiatry 2006, 45:468-475. See Ref. [7].
7. Audrain-McGovern J., Rodriguez D., Epstein L.H., Cuevas J., Rodgers K., Wileyto E.P. Does delay discounting play an etiological role in smoking or is it a consequence of smoking?. Drug Alcohol Depend 2009, 103:99-106.
8. Dalley J.W., Everitt B.J., Robbins T.W. Impulsivity, compulsivity, and top-down cognitive control. Neuron 2011, 69:680-694.
9. Evenden J.L. Varieties of impulsivity. Psychopharmacology (Berl) 1999, 146:348-361.
10. Pattij T., Vanderschuren L.J. The neuropharmacology of impulsive behaviour. Trends Pharmacol Sci 2008, 29:192-199.
11. Winstanley C.A. The utility of rat models of impulsivity in developing pharmacotherapies for impulse control disorders. Br J Pharmacol 2011, 164:1301-1321.
12. Broos N., Schmaal L., Wiskerke J., Kostelijk L., Lam T., Stoop N., Weierink L., Ham J., de Geus E.J., Schoffelmeer A.N., et al. The relationship between impulsive choice and impulsive action: a cross-species translational study. PLoS ONE 2012, 7:e36781.
13. Bowden-Jones H., McPhillips M., Rogers R., Hutton S., Joyce E. Risk-taking on tests sensitive to ventromedial prefrontal cortex dysfunction predicts early relapse in alcohol dependency: a pilot study. J Neuropsychiatry Clin Neurosci 2005, 17:417-420. See Ref. [14].
14. Paulus M.P., Tapert S.F., Schuckit M.A. Neural activation patterns of methamphetamine-dependent subjects during decision making predict relapse. Arch Gen Psychiatry 2005, 62:761-768.
15. Parvaz M.A., Alia-Klein N., Woicik P.A., Volkow N.D., Goldstein R.Z. Neuroimaging for drug addiction and related behaviors. Rev Neurosci 2011, 22:609-624.
16. Wegmann L., Buhler A., Strunk M., Lang P., Nowak D. Smoking cessation with teenagers: the relationship between impulsivity, emotional problems, program retention and effectiveness. Addict Behav 2012, 37:463-468.
17. Krishnan-Sarin S., Reynolds B., Duhig A.M., Smith A., Liss T., McFetridge A., Cavallo D.A., Carroll K.M., Potenza M.N. Behavioral impulsivity predicts treatment outcome in a smoking cessation program for adolescent smokers. Drug Alcohol Depend 2007, 88:79-82.
18. Powell J., Dawkins L., West R., Powell J., Pickering A. Relapse to smoking during unaided cessation: clinical, cognitive and motivational predictors. Psychopharmacology (Berl) 2010, 212:537-549.
19. MacKillop J., Kahler C.W. Delayed reward discounting predicts treatment response for heavy drinkers receiving smoking cessation treatment. Drug Alcohol Depend 2009, 104:197-203.
20. Yoon J.H., Higgins S.T., Heil S.H., Sugarbaker R.J., Thomas C.S., Badger G.J. Delay discounting predicts postpartum relapse to cigarette smoking among pregnant women. Exp Clin Psychopharmacol 2007, 15:176-186.
21. Billieux J., Gay P., Rochat L., Khazaal Y., Zullino D., Van der Linden M. Lack of inhibitory control predicts cigarette smoking dependence: evidence from an non-deprived sample of light to moderate smokers. Drug Alcohol Depend 2010, 112:164-167.
22. Stanger C., Ryan S.R., Fu H., Landes R.D., Jones B.A., Bickel W.K., Budney A.J. Delay discounting predicts adolescent substance abuse treatment outcome. Exp Clin Psychopharmacol 2012, 20:205-212.
23. Washio Y., Higgins S.T., Heil S.H., McKerchar T.L., Badger G.J., Skelly J.M., Dantona R.L. Delay discounting is associated with treatment response among cocaine-dependent outpatients. Exp Clin Psychopharmacol 2011, 19:243-248.
24. Passetti F., Clark L., Mehta M.A., Joyce E., King M. Neuropsychological predictors of clinical outcome in opiate addiction. Drug Alcohol Depend 2008, 94:82-91.
25. Badiani A., Belin D., Epstein D., Calu D., Shaham Y. Opiate versus psychostimulant addiction: the differences do matter. Nat Rev Neurosci 2011, 12:685-700.
26. Ersche K.D., Jones P.S., Williams G.B., Turton A.J., Robbins T.W., Bullmore E.T. Abnormal brain structure implicated in stimulant drug addiction. Science 2012, 335:601-604.
27. Shaham Y., Miczek K.A. Reinstatement-toward a model of relapse. Psychopharmacology (Berl) 2003, 168:1-2.
28. Davis W.M., Smith S.G. Role of conditioned reinforcers in initiation. Maintenance and extinction of drug-seeking behavior. Pavlov J Biol Sci 1976, 11:222-236.
29. De Wit H. Priming effects with drugs and other reinforcers. Exp Clin Psychopharmacol 1996, 4:5-10.
30. Shaham Y., Erb S., Stewart J. Stress-induced relapse to heroin and cocaine seeking in rats: a review. Brain Res Rev 2000, 33:13-33.
31. Kalivas P.W., Volkow N., Seamans J. Unmanageable motivation in addiction: a pathology in prefrontal-accumbens glutamate transmission. Neuron 2005, 45:647-650.
32. Van den Oever M.C., Spijker S., Smit A.B., De Vries T.J. Prefrontal cortex plasticity mechanisms in drug seeking and relapse. Neurosci Biobehav Rev 2010, 35:276-284.
33. Belin D., Mar A.C., Dalley J.W., Robbins T.W., Everitt B.J. High impulsivity predicts the switch to compulsive cocaine-taking. Science 2008, 320:1352-1355. See Ref. [37].
34. Dalley J.W., Fryer T.D., Brichard L., Robinson E.S., Theobald D.E., Laane K., Pena Y., Murphy E.R., Shah Y., Probst K., et al. Nucleus accumbens D2/3 receptors predict trait impulsivity and cocaine reinforcement. Science 2007, 315:1267-1270. See Ref. [37].
35. Diergaarde L., Pattij T., Poortvliet I., Hogenboom F., De Vries W., Schoffelmeer A.N.M., De Vries T.J. Impulsive choice and impulsive action predict vulnerability to distinct stages of nicotine seeking in rats. Biol Psychiatry 2008, 63:301-308. See Ref. [37].
36. Economidou D., Pelloux Y., Robbins T.W., Dalley J.W., Everitt B.J. High impulsivity predicts relapse to cocaine-seeking after punishment-induced abstinence. Biol Psychiatry 2009, 65:851-856. See Ref. [37].
37. Perry J.L., Nelson S.E., Carroll M.E. Impulsive choice as a predictor of acquisition of IV cocaine self-administration and reinstatement of cocaine-seeking behavior in male and female rats. Exp Clin Psychopharmacol 2008, 16:165-177.
38. Broos N., Diergaarde L., Schoffelmeer A.N., Pattij T., De Vries T.J. Trait impulsive choice predicts resistance to extinction and propensity to relapse to cocaine seeking: a bidirectional investigation. Neuropsychopharmacology 2012, 37:1377-1386.
39. McNamara R., Dalley J.W., Robbins T.W., Everitt B.J., Belin D. Trait-like impulsivity does not predict escalation of heroin self-administration in the rat. Psychopharmacology (Berl) 2010, 212:453-464.
40. Schippers M.C., Binnekade R., Schoffelmeer A.N., Pattij T., De Vries T.J. Unidirectional relationship between heroin self-administration and impulsive decision-making in rats. Psychopharmacology (Berl) 2012, 219:443-452.
41. Winstanley C.A., Bachtell R.K., Theobald D.E., Laali S., Green T.A., Kumar A., Chakravarty S., Self D.W., Nestler E.J. Increased impulsivity during withdrawal from cocaine-self administration: role for deltaFosB in the orbitofrontal cortex. Cereb Cortex 2009, 19:435-444.
42. Blondeau C., Dellu-Hagedorn F. Dimensional analysis of ADHD subtypes in rats. Biol Psychiatry 2007, 61:1340-1350.
43. Robinson E.S., Eagle D.M., Mar A.C., Bari A., Banerjee G., Jiang X., Dalley J.W., Robbins T.W. Similar effects of the selective noradrenaline reuptake inhibitor atomoxetine on three distinct forms of impulsivity in the rat. Neuropsychopharmacology 2008, 33:1028-1037.
44. Economidou D., Dalley J.W., Everitt B.J. Selective norepinephrine reuptake inhibition by atomoxetine prevents cue-induced heroin and cocaine seeking. Biol Psychiatry 2011, 69:266-274.
45. De Vries T.J., Schoffelmeer A.N.M., Binnekade R., Vanderschuren L.J.M.J. Dopaminergic mechanisms mediating the incentive to seek cocaine and heroin following long-term withdrawal of IV drug self-administration. Psychopharmacology (Berl) 1999, 143:254-260.
46. Schenk S., Partridge B. Cocaine-seeking produced by experimenter-administered drug injections: dose-effect relationships in rats. Psychopharmacology (Berl) 1999, 147:285-290.
47. Van Gaalen M.M., Brueggeman R.J., Bronius P.F., Schoffelmeer A.N., Vanderschuren L.J. Behavioral disinhibition requires dopamine receptor activation. Psychopharmacology (Berl) 2006, 187:73-85.
48. Winstanley C.A., Chudasama Y., Dalley J.W., Theobald D.E., Glennon J.C., Robbins T.W. Intra-prefrontal 8-OH-DPAT and M100907 improve visuospatial attention and decrease impulsivity on the five-choice serial reaction time task in rats. Psychopharmacology (Berl) 2003, 167:304-314.
49. Dhonnchadha B., Fox R., Stutz S., Rice K., Cunningham K. Blockade of the serotonin 5-HT2A receptor suppresses cue-evoked reinstatement of cocaine-seeking behavior in a rat self-administration model. Behav Neurosci 2009, 123:382-396.
50. Wilens T.E., Morrison N.R. The intersection of attention-deficit/hyperactivity disorder and substance abuse. Curr Opin Psychiatry 2011, 24:280-285.
51. Sonuga-Barke E.J. Causal models of attention-deficit/hyperactivity disorder: from common simple deficits to multiple developmental pathways. Biol Psychiatry 2005, 57:1231-1238.
52. Li C.S., Morgan P.T., Matuskey D., Abdelghany O., Luo X., Chang J.L., Rounsaville B.J., Ding Y., Malison R.T. Biological markers of the effects of intravenous methylphenidate on improving inhibitory control in cocaine-dependent patients. Proc Natl Acad Sci USA 2010, 107:14455-14459.
53. Goldstein R.Z., Volkow N.D. Oral methylphenidate normalizes cingulate activity and decreases impulsivity in cocaine addiction during an emotionally salient cognitive task. Neuropsychopharmacology 2011, 36:366-367.
54. Schubiner H., Saules K.K., Arfken C.L., Johanson C.E., Schuster C.R., Lockhart N., Edwards A., Donlin J., Pihlgren E. Double-blind placebo-controlled trial of methylphenidate in the treatment of adult ADHD patients with comorbid cocaine dependence. Exp Clin Psychopharmacol 2002, 10:286-294.
55. Castells X., Casas M., Perez-Mana C., Roncero C., Vidal X., Capella D. Efficacy of psychostimulant drugs for cocaine dependence. Cochrane Database Syst Rev 2010, 2:CD007380.
56. Grabowski J., Rhoades H., Stotts A., Cowan K., Kopecky C., Dougherty A., Moeller F.G., Hassan S., Schmitz J. Agonist-like or antagonist-like treatment for cocaine dependence with methadone for heroin dependence: two double-blind randomized clinical trials. Neuropsychopharmacology 2004, 29:969-981.
57. Greenwald M.K., Lundahl L.H., Steinmiller C.L. Sustained release d-amphetamine reduces cocaine but not 'speedball'-seeking in buprenorphine-maintained volunteers: a test of dual-agonist pharmacotherapy for cocaine/heroin polydrug abusers. Neuropsychopharmacology 2010, 35:2624-2637.
58. Wilens T.E., Adler L.A., Weiss M.D., Michelson D., Ramsey J.L., Moore R.J., Renard D., Brady K.T., Trzepacz P.T., Schuh L.M., et al. Atomoxetine ADHD/SUD Study Group: atomoxetine treatment of adults with ADHD and comorbid alcohol use disorders. Drug Alcohol Depend 2008, 96:145-154.
59. Wilens T.E., Adler L.A., Tanaka Y., Xiao F., D'Souza D.N., Gutkin S.W., Upadhyaya H.P. Correlates of alcohol use in adults with ADHD and comorbid alcohol use disorders: exploratory analysis of a placebo-controlled trial of atomoxetine. Curr Med Res Opin 2011, 27:2309-2320.
60. Levin F.R., Mariani J.J., Secora A., Brooks D., Cheng W.Y., Bisaga A., Nunes E., Aharonovich E., Raby W., Hennessy G. Atomoxetine treatment for cocaine abuse and adult attention-deficit hyperactivity disorder (ADHD): a preliminary open trial. J Dual Diagn 2009, 5:41-56.
61. McRae-Clark A.L., Carter R.E., Killeen T.K., Carpenter M.J., White K.G., Brady K.T. A placebo-controlled trial of atomoxetine in marijuana-dependent individuals with attention deficit hyperactivity disorder. Am J Addict 2010, 19:481-489.
62. Kreek M.J., Nielsen D.A., Butelman E.R., LaForge K.S. Genetic influences on impulsivity, risk taking, stress responsivity and vulnerability to drug abuse and addiction. Nat Neurosci 2005, 8:1450-1457.
63. Epstein D.H., Preston K.L., Stewart J., Shaham Y. Toward a model of drug relapse: an assessment of the validity of the reinstatement procedure. Psychopharmacology (Berl) 2006, 189:1-16.
64. Volkow N.D., Swanson J.M. Variables that affect the clinical use and abuse of methylphenidate in the treatment of ADHD. Am J Psychiatry 2003, 160:1909-1918.